Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell
Phase 1
- Conditions
- Ischemia
- Registration Number
- NCT00518934
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
The purpose of this study is to analyze the safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cells.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with ischemic symptoms such as claudication, rest pain or nonhealing ischemic wound
- Without evidence of improvement in response to conventional medical therapy
- Not candidates for surgical intervention or radiologic intervention
Exclusion Criteria
- Malignant disease
- More than 60 years old
- Other significant medical conditions, including diabetes mellitus, hypertension, hyperlipidemia, etc.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Samsung Medical Center, Sungkyunkwan University School of Medicine
🇰🇷Seoul, Korea, Republic of